Tag : HEMLIBRA

Latest News

Genentech Presents a Broad Range of Data for Hemlibra (Emicizumab-kxwh) Demonstrating Continued Benefits for People With Hemophilia A at the ISTH 2019 Congress

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data for Hemlibra® (emicizumab-kxwh) across multiple...
Latest News

Riassunto: L'ente statunitense preposto al controllo dei farmaci e degli alimenti (Food and Drug Administration, FDA) approva HEMLIBRA® di Chugai per il trattamento dell'emofilia A senza inibitori

Newsemia
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) ha annunciato in data odierna che l’ente statunitense preposto al controllo dei farmaci e degli alimenti (Food and Drug...
Latest News

Samenvatting: Resultaten van de wereldwijde fase III proef met Chugai's HEMLIBRA® voor Hemofilie A zonder remmers gepubliceerd in New England Journal of Medicine

Newsemia
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) kondigde vandaag de resultaten aan van de HAVEN 3 proef (NCT02847637), de wereldwijde fase III studie voor het hemofilie...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy